Global Diabetes Treatments Market, By Type of Diabetes (Type-1, Type-2), Product (Insulin, Oral Hypoglycaemic Drugs, Non-Insulin Injectable Drugs), Devices (Blood Glucose Meters and Strips, Continuous Glucose Monitors (CGMs), Flash Glucose Monitoring Device, Injection Pens, Insulin Pumps, Automated Insulin Delivery Systems), End User (Hospital, Personal Use, Clinic) - Industry Trends and Forecast to 2030.
Diabetes Treatments Market Analysis and Size:
The increasing prevalence of diabetes and technological advancements in innovative diabetes treatments have significantly improved the design and functionality of the diabetes treatments market and have carved the way for the growth of the diabetes treatments market. The market for diabetes treatment has been growing steadily due to several factors. Firstly, rising healthcare expenditure has been a driver in the market. In addition, an increasing geriatric population contributes to the market for diabetes treatments market.
Data Bridge Market Research analyses that the global diabetes treatments market which was USD 5,370.2 million in 2022, would rocket up to USD 8,920.9 million by 2030, and is expected to undergo a CAGR of 6.5 % during the forecast period. Type-1 segment dominates the type segment of the diabetes treatments market owing to the advancements in technology that have led to the development of advancements diabetes treatment for various use. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Diabetes Treatments Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customisable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type of Diabetes (Type-1, Type-2), Product (Insulin, Oral Hypoglycaemic Drugs, Non-Insulin Injectable Drugs), Devices (Blood Glucose Meters and Strips, Continuous Glucose Monitors (CGMs), Flash Glucose Monitoring Device, Injection Pens, Insulin Pumps, Automated Insulin Delivery Systems), End User (Hospital, Personal Use, Clinic),
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Roche Products Limited (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Sanofi-Deutschland GmbH (Germany), Novo Nordisk A/S (Germany), ARKRAY USA, Inc. (U.S.), Bayer AG (U.S.), Amylin Pharmaceuticals Inc. (U.S.), Abbott (U.S.), Medtronic Inc. (U.S.), Teva Pharmaceuticals Pvt Ltd.(U.S.), Home Diagnostics Inc. (U.S.), Novartis AG. (U.S.), Eli Lilly and Company. (U.S.), Merck & Co., Inc, .(U.S.), AstraZeneca (U.K.), Boehringer Ingelheim International GmbH (Germany), Takeda Pharmaceutical Company Limited (Japan)
|
|
Market Opportunities
|
|
Market Definition
The global diabetes treatments market refers to the market for products, medications, devices, and therapies used to treat and manage diabetes. Diabetes is a chronic medical condition characterized by high blood sugar levels resulting from the body's inability to produce or effectively use insulin, a hormone responsible for regulating blood glucose levels.
Global Diabetes Treatments Market Dynamics
Drivers
- Increasing prevalence of diabetes
The rising prevalence of diabetes worldwide is a significant driver for the market. The disease is reaching epidemic proportions due to sedentary lifestyles, unhealthy diets, and an aging population. As the number of people with diabetes grows, the demand for effective treatments and management options increases.
- Growing awareness and education
Increased awareness about diabetes and its complications has driven the demand for diabetes treatments. Education campaigns and initiatives by healthcare organizations, governments, and patient advocacy groups have led to earlier diagnosis, better management practices, and increased demand for effective treatment options.
- Technological advancements
Advances in medical technology have led to the development of innovative diabetes treatments. Continuous glucose monitoring systems, insulin pumps, and other devices have improved the management of diabetes and enhance patient outcomes. Technological advancements continue to drive the market by offering more precise and convenient treatment options.
Opportunities
- Rising Healthcare Expenditure
Global healthcare expenditure is rising, driven by increased healthcare access, economic growth, and government initiatives to improve healthcare infrastructure. As a result, more resources are being allocated to diabetes management and treatment, which fuels market growth.
- Government Initiatives and Support
Governments worldwide are implementing initiatives to combat diabetes and its complications. These initiatives include awareness campaigns, early screening programs, reimbursement policies, and incentives for developing and adopting innovative treatments.
Restraints/ Challenges
- High cost of diabetes treatments
Diabetes management requires long-term medication, monitoring devices, and insulin therapy, which can be expensive for many patients. The high cost of diabetes treatments can limit access to proper care, particularly in developing countries or for individuals with limited financial resources.
- Limited reimbursement policies:
In certain regions, reimbursement policies may not adequately cover the costs associated with diabetes treatments. This can create a barrier for patients to access necessary medications and technologies, leading to suboptimal management of their condition.
This Global diabetes treatments market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Global diabetes treatments market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In May 2023, Abbott announced a series of new programs within its multi-million-dollar initiative to increase diversity in clinical trials and improve care among under-represented populations. The new additions to Abbott's Diversity in Clinical Trials initiative build on the partnerships, scholarships, and the focus on diversified participants in the company's clinical trials during the initiative's first year
- In December 2022, Merck KGaA, a leading science and technology company, announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., Cambridge, Massachusetts, USA to discover novel antibody-drug conjugates (ADCs) leveraging Mersana's proprietary Immunosynthen STING-agonist ADC platform, directed against up to two targets
Global Diabetes Treatments Market Scope
The global diabetes treatments market is segmented on the basis of type, product, devices, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Type 1
- Type 2
Product
- Insulin
- Oral Hypoglycemic Drugs
- Non-Insulin Injectable Drugs
Devices
- Blood Glucose Meters and Strips
- Continuous Glucose Monitors (CGMs)
- Flash Glucose Monitoring Device
- Injection Pens
- Insulin Pumps
- Automated Insulin Delivery Systems
End user
- Hospital
- Personal Use
- Clinic
Global diabetes treatments market regional analysis/insights
The global diabetes treatments market is analysed and market size insights and trends are provided product type, application, and end user, as referenced above.
The countries covered in the global diabetes treatments market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa.
North America dominates the diabetes treatments market due to major key players, high disposable income, high healthcare expenditure, and well-developed healthcare sector in this region.
Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The Global diabetes treatments market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Global diabetes treatments market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Global diabetes treatments market. The data is available for historic period 2015-2020.
Competitive Landscape and Global diabetes treatments market share Analysis
The Global diabetes treatments market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the global diabetes treatments market are:
- Roche Products Limited (Switzerland)
- Johnson & Johnson Services, Inc. (U.S.)
- Sanofi-Deutschland GmbH (Germany)
- Novo Nordisk A/S(Germany)
- ARKRAY USA, Inc. (U.S.)
- Bayer AG (U.S.)
- Amylin Pharmaceuticals Inc. (U.S.)
- Abbott (U.S.)
- Medtronic Inc. (U.S.)
- Teva Pharmaceuticals Pvt Ltd. (U.S.)
- Home Diagnostics Inc. (U.S.)
- Novartis AG (U.S.)
- Eli Lilly and Company. (U.S.)
- Merck & Co., Inc (U.S.)
- AstraZeneca (U.K.)
- Boehringer Ingelheim International GmbH (Germany)
- Takeda Pharmaceutical Company Limited (Japan)
SKU-